Skip to main content

Table 4 Multivariable-adjusted risk ratios (RR) and 95 % confidence intervals (95 % CI) for associations of reproductive risk factors and contralateral breast cancer (CBC), by estrogen receptor (ER) status of first breast cancer and menopausal status 2 years prior to first breast cancer diagnosis

From: Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study

 

ER-positive first tumors

ER-negative first tumors

P heterogeneity

Premenopausal

Postmenopausal

Premenopausal

Postmenopausal

N, cases/controls

Multivariablea RR (95 % CI)

N, cases/controls

Multivariablea RR (95 % CI)

N, cases/controls

Multivariablea RR (95 % CI)

N, cases/controls

Multivariablea RR (95 % CI)

Age at menarche (years)

 ≤11

94/205

1.0 (ref.)

65/63

1.0 (ref.)

72/83

1.0 (ref.)

27/23

1.0 (ref.)

 

 12

166/219

1.74 (1.20, 2.53)

60/81

0.63 (0.36, 1.13)

95/108

0.96 (0.58, 1.58)

35/25

1.75 (0.71, 4.33)

 

 13

168/236

1.56 (1.08, 2.27)

41/85

0.29 (0.16, 0.52)

97/121

1.12 (0.69, 1.81)

23/30

0.75 (0.30, 1.86)

 

 ≥14

153/271

1.33 (0.91, 1.93)

46/85

0.45 (0.25, 0.81)

81/120

0.79 (0.48, 1.32)

30/44

0.45 (0.20, 1.04)

 

 P btrend

 

0.33

 

0.001

 

0.62

 

0.01

0.0001

Full-term pregnancies at first diagnosis

 None

133/187

1.0 (ref.)

40/60

1.0 (ref.)

76/82

1.0 (ref.)

18/16

1.0 (ref.)

 

 ≥1

449/744

0.87 (0.65, 1.15)

172/253

1.22 (0.74, 2.00)

272/353

0.97 (0.63, 1.48)

96/107

0.84 (0.36, 1.95)

0.71

Number of full-term pregnancies at first diagnosisc

 1

111/146

1.0 (ref.)

32/52

1.0 (ref.)

56/78

1.0 (ref.)

15/21

1.0 (ref.)

 

 2

221/369

0.99 (0.65, 1.49)

67/93

1.53 (0.74, 3.14)

140/175

1.02 (0.60, 1.74)

41/37

1.41 (0.41, 4.93)

 

 3

89/156

1.00 (0.62, 1.61)

45/53

1.22 (0.54, 2.75)

56/63

1.03 (0.53, 1.98)

25/28

1.57 (0.56, 4.42)

 

 ≥4

28/73

0.41 (0.20, 0.82)

28/55

0.81 (0.34, 1.94)

20/37

0.64 (0.28, 1.44)

15/21

1.43 (0.44, 4.68)

 

 P btrend

 

0.03

 

0.28

 

0.28

 

0.52

0.98

Age at first full-term pregnancy at reference date (years)c

 <20

46/92

1.0 (ref.)

32/60

1.0 (ref.)

41/44

1.0 (ref.)

29/24

1.0 (ref.)

 

 20–24

136/252

1.12 (0.63, 1.96)

75/105

1.25 (0.64, 2.47)

104/117

1.14 (0.58, 2.21)

42/53

0.76 (0.32, 1.78)

 

 25–29

152/246

1.24 (0.70, 2.18)

44/68

1.38 (0.65, 2.95)

72/108

0.61 (0.31, 1.22)

18/23

0.51 (0.18, 1.47)

 

 ≥30

115/154

1.35 (0.74, 2.47)

21/20

2.30 (0.84, 6.25)

55/84

0.64 (0.30, 1.41)

7/7

0.87 (0.19, 3.92)

 

 P btrend

 

0.28

 

0.13

 

0.03

 

0.40

0.17

Breastfeeding at reference date (months)c

 Never

111/198

1.0 (ref.)

69/106

1.0 (ref.)

98/106

1.0 (ref.)

38/43

1.0 (ref.)

 

 Ever

338/546

1.26 (0.87, 1.81)

103/147

0.90 (0.52, 1.54)

172/246

0.62 (0.40, 0.96)

58/64

0.72 (0.34, 1.51)

0.07

 ≤6

164/259

1.31 (0.87, 1.97)

58/89

0.74 (0.40, 1.36)

75/127

0.59 (0.35, 1.00)

34/44

0.59 (0.25, 1.38)

 

 7–12

63/118

1.10 (0.65, 1.87)

19/29

1.13 (0.48, 2.63)

51/43

0.94 (0.49, 1.79)

14/10

0.83 (0.26, 2.67)

 

 13–24

72/112

1.24 (0.74, 2.08)

14/20

1.33 (0.41, 4.35)

28/46

0.71 (0.35, 1.48)

7/4

1.59 (0.23, 10.8)

 

 ≥25

39/57

1.78 (0.93, 3.38)

12/9

1.50 (0.37, 6.04)

18/30

0.37 (0.16, 0.86)

3/6

1.23 (0.17, 9.17)

 

 P btrend

 

0.20

 

0.28

 

0.06

 

0.71

0.19

Time between menarche and first full-term pregnancy at reference date (years)c

 <10

119/237

1.0 (ref.)

72/118

1.0 (ref.)

90/102

1.0 (ref.)

50/54

1.0 (ref.)

 

 10–14

161/260

1.26 (0.85, 1.870

56/91

1.52 (0.82, 2.81)

96/121

0.86 (0.51, 1.44)

31/42

0.91 (0.41, 1.99)

 

 15–19

103/160

1.32 (0.84, 2.06)

27/31

1.85 (0.84, 4.04)

56/81

0.72 (0.40, 1.29)

9/6

1.74 (0.39, 7.81)

 

 ≥20

65/86

1.25 (0.74, 2.08)

17/13

3.70 (1.27, 10.9)

28/46

0.46 (0.21, 1.01)

6/3

1.42 (0.26, 7.93)

 

 P btrend

 

0.30

 

0.009

 

0.05

 

0.59

0.17

  1. aAdjusted for age at first diagnosis, histology at first diagnosis, family history, stage at first diagnosis, chemotherapy/hormonal treatment for first diagnosis, use of postmenopausal hormone therapy up to first diagnosis, age at menarche, age at menopause and parity, with offset for countermatching
  2. bAmong parous women only, additionally mutually adjusted for age at first FTP, number of FTP, breastfeeding
  3. c P trend calculated by modeling category medians continuously. Estimates for time since last full-term pregnancy and interval pregnancies not shown due to small numbers